The Boeing Company
Builds passenger jets and military aircraft, selling to airlines and government defense customers.
Ratify Underweight rating by maintaining a ≤0.5% portfolio risk residual with a 50% trim into rallies at $195-200, a hard close-stop at $170 (tightening to $178 pre-earnings), and converting up to 40% of trim proceeds into a 195-200/175/230 defined-risk collar structure. No new longs ahead of late-October Q3 earnings and no shorting per borrow/squeeze gating, with re-engagement tied to catalyst resolution and technical repair rather than price chasing.
24 wins · 11 losses · 9 pushes in 44 scored verdicts How this is scored
Free accounts read most reports by the next trading session, every report within 7 days — subscribers read it the same day.
Create a free account0.0%
$10,000 → $10,000
Report archive
Subscribe to read
Subscribe to read
last 30 of 49 reports24 wins · 11 losses · 9 pushes in 44 scored verdicts-0.46% avg move
-18.7%
$10,000 → $8,127
too few trades to judge — no round trips yetin the market 0 of 44 sessionsmax drawdown 0.0%simulated 10 Aug – 9 Oct 20265 newer calls are locked
Simulated with a notional $10,000, fills at the next session's open, no commissions or slippage, split- and dividend-adjusted prices. Not a return forecast. How this is simulated
Subscribe to read
Subscribe to read
Subscribe to read
Ratify Underweight rating by maintaining a ≤0.5% portfolio risk residual with a 50% trim into rallies at $195-200, a hard close-stop at $170 (tightening to $178 pre-earnings), and converting up to 40% of trim proceeds into a 195-200/175/230 defined-risk collar structure. No new longs ahead of late-October Q3 earnings and no shorting per borrow/squeeze gating, with re-engagement tied to catalyst resolution and technical repair rather than price chasing.
Ratify Underweight rating at $188 executed as a modest trim (~1.0% NAV cap, 30-40% reduction of existing longs) rather than max-conviction short, reflecting proximity to the $184 institutional floor and $181 lower Bollinger band. Refine the $197 stop to a closing-stop or volume-confirmed basis (>10M shares) to reduce whipsaw risk from dead-cat bounces, with explicit prohibition on scaling into shorts on rallies to $192/$197.
Trim Boeing exposure by 30-40% at current prices ($189.82), capping residual at 1.0% of NAV, with a layered stop structure (first tranche at $182.23, final stop at $176.77) and mandatory pre-earnings exit of at least half the residual position before Q3 2026 results to neutralize binary event risk while preserving participation in potential relief rallies.
Analysts maintain Hold on this aerospace manufacturer, rejecting both aggressive spot-buying into flushes and conservative underweight rigidity. The preferred approach uses options-based optionality (long-dated calls or 195/180 put spreads at 30-45 days) rather than direct equity exposure to capture asymmetric upside without violating position discipline. The 184 stop level is treated as a structural guideline to reassess around catalyst events rather than a hard exit trigger, with 25-33% trimming recommended on any relief rally into the 198-200 resistance zone.
Maintain Hold on Boeing at $192.28 with a trigger-loaded entry framework rather than initiating new longs now. The Neutral analyst's calibrated execution parameters are adopted: entry on confirmed close above $200.82 with ≥15M volume, stop at $180.50, 1% portfolio risk sizing in two tranches, and a 15-trading-day time stop—improving R:R to ~1.3:1 while awaiting catalyst resolution (IAM 751 vote, Q3 2026 earnings ~late October, F/A-XX decision).
Maintain HOLD at 2-3% portfolio cap with active management overlay. Trim 25-33% of position on any relief rally to $198-200 (former support now resistance; 10 EMA at $194.17). Tighten stop to $183 with realistic gap modeling to $176-177. Consider harvesting elevated implied volatility via covered calls at $200-205 strikes for October/November expiry. Re-engage in tranches tied to catalyst resolution: tranche one post-IAM 751 vote, tranche two post-Q3 positive FCF + gross margin >10%, tranche three on confirmed 200 SMA reclaim with volume ≥1.5x 20-day average and RSI > 40.
Maintain HOLD at 2-3% portfolio cap; do not initiate new exposure. The capitulation signal (RSI sub-30, closes below lower Bollinger Band) is real, but Aggressive Buy fails on flawed risk/reward arithmetic (realistic 1.7:1 vs claimed 3:1) and CEO's "production not stable" admission signals asymmetric downside risk. The bearish facts are correct but Underweight fails because unanimous bear consensus at confirmed capitulation lows argues for preserving floor participation rather than directional underweight. Hold with refined triggers is the only framework that respects all three constraints: capitulation signature, confirmed breakdown, and $187 institutional floor.
Maintain BA at HOLD given convergence of three analysts—the structural bullish case ($62.6B deferred, duopoly) offsets broken technicals (all MAs stacked bearishly, RSI 27→32) and 45x forward P/E valuation. Do not initiate fresh exposure at $184-187; deploy via tiered framework with first tranche on momentum stabilization (higher low above $184, RSI curling toward 40) and second larger tranche on 10 EMA reclaim at ~$196 with volume.
Maintain HOLD at $184 with a three-tranche re-entry architecture: 25% on confirmed momentum exhaustion (RSI higher low + price higher low), 25% on daily close above 10 EMA at $197.81, and final 50% only after 5 consecutive sessions above the declining 50 SMA (~$205-208) or 3 consecutive closes above $190 with declining ATR. Hard stop remains at $176, with options spreads (195/180 put spread at 30-45 days) recommended as a documented hedge to express a moderately bullish view without committing new capital at this thin 3.6% cushion above the floor.
Underweight at 50-60% portfolio cap is warranted given bearish technicals (price below all MAs, expanding MACD histogram, RSI at 37 in confirmed downtrend) and 47x forward P/E on trough margins, but full Sell is rejected due to institutional floor ($62.6B deferred revenue, $620B backlog, $187 structural low) and three specific execution failures in the trader's $210/$218 architecture; staged trim at $198-200 (50-60%), $208 limit (20-30%), and residual 20-30% honors the floor with hard stop at $187.
Maintain Underweight rating with 0.5-1.0% portfolio cap and 30-50% staged trim strategy on rallies toward $205-210, retaining 20-30% residual to honor the institutional floor ($62.6B deferred, $620B backlog, $20.9B liquidity). Hard stop set at $187 on heavy volume (structural floor breach), with optional 195/180 put spread hedge at IV <45% to define downside while preserving upside participation in the binary catalyst cluster (Q3 2026 earnings, F/A-XX decision, FOMC).
The analysts maintain Underweight on Boeing given broken technical trend (price below 10 EMA $202.42, 50 SMA $215.12, 200 SMA $221.15), death cross forming, rich 49x forward P/E, CEO's admission that 737 MAX production "is not stable," and binary catalyst risk from the Trump-Xi summit (~2 days) and F/A-XX decision. The preferred execution is a staged trim: 10-15% near $199-200 at market or 1-3 day horizon, 10-15% as limit sells at $202-206 on confirmed rejection, retaining 20-30% residual to honor the institutional floor ($62.6B deferred revenue, $620B backlog, $20.9B liquidity) while hedging with a 195/180 put spread at 30-45 days to capture elevated IV.
Trim Boeing to a 0.5-1.0% residual floor at current levels (~$197.72) rather than waiting for a rally, hedge the residual with a December $195/$175 put spread, and tighten the stop on remaining exposure to $202.98 (10 EMA). The Underweight rating is maintained over Sell because the institutional floor ($187 structural low, $62.6B deferred revenue, $620B backlog) and recent failed Sell-call pattern argue for sizing discipline, not aggressive shorting into a binary Trump-Xi summit event on September 24.
Trim Boeing exposure to 0.5-1.0% of portfolio from current larger allocations. Maintain Underweight rather than Sell due to two failed recent Sell calls at similar capitulation setups; the September 24 Trump-Xi summit creates binary risk on 20-25% of backlog. Capture ~80% of downside alpha with materially less left-foot risk, re-assessing at Q3 2026 earnings.
Sell BA with staged execution: 50-60% trim via market-on-close or 1-3 day horizon, 20-30% via limit sells in the $204-208 zone to capture relief bounces, and 20-30% residual underweight retained as institutional floor (retain due to $62.6B deferred revenue, $620B backlog, and ~$187 structural low that has held every drawdown). Reject the trader's $204 entry/$209 stop tactical short as mathematically broken (~$5 stop = ~1 ATR on a $5.56 ATR name), and reject pure Underweight via Hold execution since consensus + confirmed bear = ≥70% trim per the 9/15 BA lesson.
Analysts unanimously recommend aggressively trimming Boeing (BA) to SELL given confirmed technical breakdown below all moving averages and the lower Bollinger Band, with consensus citing demonstrated operating FCF weakness (-$3-4B annualized), CEO-admitted 737 MAX production instability, and hostile macro environment (recession odds rising, rates at 2007 highs). The recommended execution prioritizes 50-60% immediate market-on-close sales to avoid repeating the 9/16 failure where limit sells at $206-208 left two-thirds of alpha uncollected when the stock gapped through; retain 20-30% residual underweight as structural floor participation via defense backlog and deferred revenue, with optional $180-190 puts (60-90 day expiry) if IV below 45%.
All three analysts converge on SELL for Boeing, citing confirmed bear case with technical breakdown (death cross forming, 50 SMA lost on 2x volume), catastrophic fundamentals ($1.45B quarterly FCF burn, 0.004% operating margin, P/E 49.4×), and hostile macro environment (Fed hikes, 95% probability of no cuts through 2026). Staged exit recommended: 60-70% as limit sells in $213-217 zone, remaining 30-40% on trailing stop or market-on-close if $197 breaks.
Portfolio managers maintain HOLD on BA with ≤1.0% portfolio allocation (down from 1.5%), rejecting tactical adds at current levels due to death cross technicals ($217.90 50-day below $221.03 200-day), negative Q1 2026 FCF of -$1.45B, and 51x forward P/E. Pre-committed triggers include a 25% add on confirmed close above $217.90 with volume ≥5M targeting $220-225, trim 25-35% into $215-218 resistance, and hard stop at $190.52 structural low.
Maintain BA at reduced weight (≤1.5% of portfolio vs. 2.5% Russell 1000 Industrials benchmark) — this executes Underweight via sizing discipline rather than directional short. Trim 30-50% on relief rallies into $215-218 (50 SMA region) with hard stop at $204; do not add at current $210 levels where 51x forward P/E with -$1.45B Q1 2026 FCF does not justify new capital. Reassess after Q3 2026 earnings, FOMC, and NGAD/F/A-XX decision.
Trim Boeing by 25–35% via staged execution into the $213.15–$215 resistance zone (Bollinger middle / prior support-turned-resistance), with a second conditional tranche only on confirmed failure at the 50 SMA ($218.72). Hold residual 50–60% of original position with $220.74 as thesis-invalidation level—not a mechanical stop. Optional protective puts (Dec 2026, $195–205 strike) on 10–15% of residual ONLY if implied vol is below 45%; skip if vol is priced into the catalyst cluster.
Maintain BA at current weight with a hard stop at $196.50. Do not add capital until either confirmed close above $200 on volume with oversold reversal signal, or successful Fed/catalyst resolution without breakdown. Tighten add-on sizing to 25% of normal conviction maximum and reassess at the Sept 16 Fed meeting, F/A-XX decision, and Q3 2026 earnings (~late October).
Boeing merits Underweight because the structural bear case is stronger than the bull case, supported by BA trading below its declining 10-, 50-, and 200-day moving averages with $220.46 now overhead resistance and approximately 50x forward earnings attached to a 0.004% operating margin. Existing holders should reduce exposure by 40-50% rather than exit entirely, while a tactical short overlay is appropriate only if BA rallies into $215-$220 and confirms rejection below resistance, with $224 as the stop-loss and $185 as the 3-6 month downside objective.
Analysts recommend trimming Boeing to 50-60% of benchmark weight via scale-out tranches at/near spot ($210-211) up to $217-219, maintaining a hard stop at $200.00 and rejecting both a full SELL and passive HOLD given 6+ converging bearish signals including death cross, negative MACD, and 51x forward P/E. Mechanical re-engagement is triggered only on daily close above $220 with volume ≥7M and MACD histogram confirming no new lows for 2+ sessions, with reassessment points at the Sept 8 SPEEA outcome, Sept 24 Xi-Trump summit, and Q3 2026 earnings.
Maintain a 30-40% underweight trim targeting $210-213 via scale-out at spot, avoiding limit orders above current price or chasing into the $217-$220 death-cross resistance band; hard stop set at $200.00 (below round-number floor and lower Bollinger, above March 2026 structural low at ~$187), with a single re-engagement trigger of daily close above $220 on volume ≥7M with MACD histogram no new lows for 2+ sessions. The bear case rests on 49x forward P/E embedding near-perfect execution while operating cash flow remains negative ($179M most recent quarter) and TTM EBITDA is -$2.9B, balance sheet healing driven by the $10.55B Digital Aviation Solutions divestiture rather than organic improvement, and a technically bearish setup (price below death cross at $219.53/$220.14, -12% YTD vs S&P +20.5%); however, Underweight rather than full Sell is warranted due to institutionally thick structural floors ($62.6B deferred revenue, $500B+ backlog, $20.9B liquidity) that bound drawdown.
Trim Boeing to 30-40% below benchmark on a scale-out basis across three tranches ($210, $213-215, $217-220 cap) given 51x forward P/E pricing in near-perfect execution, negative operating cash flow, confirmed death cross technicals, and -$1.45B Q1 2026 FCF cushion, while maintaining hard stop at $200 and reassessing post-SPEEA catalyst on September 8 and Q3 2026 earnings.
Maintain BA at Hold with a probability-weighted value of approximately $203, offering little margin of safety against the $208.87 reference price; avoid fresh entry before the September 8 SPEEA labor outcome, as the weak technical setup and binary risk make current levels unattractive, though the stock merits neutral weight over Underweight given the structural floor from balance-sheet repair and $85B defense backlog.
Trim BA to 0.5-0.75% of portfolio (aggressive end of underweight range) by scaling out of existing long at/near spot $205-207, not via the trader's rejected SELL structure with broken $209.50 entry and sub-ATR $213.50 stop. Hard stop on residual at $200.00 (~1.5 ATR below spot), with single mechanical re-engagement trigger: close above $220 (50 SMA) on volume ≥7M with MACD histogram no new lows for 2+ sessions. Rotate proceeds into LMT/RTX/GD on 5-day VWAP basis; reassess at Sep 8 SPEEA talks and Q3 2026 earnings.
The Underweight rating on Boeing is maintained with a recommendation to trim to 45-50% of target weight via scale-out at/near $207.78, using a $200 hard stop. A single re-engagement trigger exists: close above $220.80 (50 SMA) on volume ≥7M with MACD histogram no new lows for 2+ sessions. The thesis is supported by five prior Underweight decisions that produced +0.2% to +1.7% alpha, with key risks including SPEEA labor disruption potentially costing $1.6-3.2B (30-60% of TTM FCF), 50.4x forward P/E pricing in near-perfect execution, and death cross formation $0.57 away.
Trim Boeing to 55% of current weight (Underweight, not full Sell) with a $200 technical stop replacing the $215 level, and hedge residual 7-8% of notional via Dec 2026 $200 puts; fresh allocation capped at 1%. Explicit escalation triggers include SPEEA strike, close below $203.58 on volume >7M, or $2B+ defense charge; re-entry requires SPEEA resolution, operating margin above 4%, or reclaim of $220 50 SMA on volume ≥7M. Price target $260, reassess at Q3 2026 earnings.
Trim BA to 40-45% of target weight via a 45-50% scale-out of current allocation, executing first tranche at/near spot $209-211, second into $213-215 strength, and third cap at $215-218 on any Jackson Hole relief bounce. Set hard stop on residual at $200 (1.8 ATR buffer), employ put-spread overlay for defined-risk hedging given elevated 51x forward P/E and binary catalysts, and re-engage only on daily close above $220.80 (50 SMA) on volume ≥7M with MACD histogram no new lows for 2+ sessions. Reassess at Q2 2026 earnings and post-Jackson Hole with $260 price target representing recovery thesis.
Reduce Boeing to 50-55% of target weight by trimming at/near current market ($211-213), then scaling out on bounces to $215-216 and $218-220; place protective stop at $202-203 (approximately 1.7 ATRs given the 5.65 ATR), not the too-tight $205 level. Re-engage only if BA closes above $221.15 (50 SMA) on volume ≥7M with MACD histogram no new lows, and reassess fully at Q3 2026 earnings (~late October).
Trim 30-35% of BA exposure at current $211 area (floor at or below spot) while retaining 65-70% as a managed core, with hard stop on residual at $199.00 (not $206, which sits only ~0.85 ATR from entry and would auto-clip on death cross noise; $199 sits 2.0 ATR below current price below round-number support). Position at no more than 60% of benchmark weight. Simple re-engagement only: close > $219 on volume ≥7M shares with MACD histogram no new lows. Reassess at death cross completion (~2-4 weeks) and Q3 2026 earnings (~late October).
Trim Boeing by 40-45% of current holdings to ~55-60% of benchmark weight, with full exit triggered below $208.38 on volume >7M shares; do not initiate new longs at $210.46. Three explicit re-entry triggers defined: (1) close above $226 on volume >7.5M with improving MACD histogram, (2) confirmed SPEEA settlement removing binary labor overhang, or (3) capitulation flush to $195-$189 with RSI <30. Rating lands at Underweight rather than Sell because the $400B+ backlog, $62.6B deferred revenue, and defense contract ceiling warrant retaining a residual core as a structural floor, while Hold is rejected because at 75.7x TTM P/E with zero operating margin in hostile macro, Hold functions as a slow-motion liquidation.
Maintain BA position with tiered accumulation framework capping allocation at 3% of portfolio and hard stop at $189. Current price of $214.20 is too risky for initiation without confirmation—first tranche requires close above $223 on ≥1.2x average volume. Existing longs should trim 20-25% on any rally to $230-235 while maintaining core position. 12-month horizon acknowledges near-term downside (macro rotation, technical breakdown, 52x forward P/E) while preserving asymmetric upside participation if structural thesis (524B backlog, restored equity, defense contracts) validates.
Reduce Boeing (BA) to 50-60% of benchmark weight by trimming 40-50% of current holdings opportunistically in the $215-$225 zone (spot $215.10 is already below the broken 200-SMA at $219.47), with a hard stop on residual at $224-$226 (~1.5x ATR); do not chase exits — execute on bounces into the zone rather than waiting for $219.47 tag. Re-entry requires two consecutive closes above $225 on rising volume AND quarterly FCF showing sequential improvement with organic FCF no worse than -$500M; reassess by Q1 2027 if no trigger fires.
Trim existing Boeing (BA) positions on any rally into the $226-232 zone while maintaining 50-60% core exposure; do not initiate new longs at current $222 levels. Hard stop exits are triggered on confirmed daily close below $219.40 (200 SMA) with volume above 7M shares. Position sizing must respect 1.22-beta volatility with total stop-basis risk capped at 2% of NAV and no leverage or concentration added.
Trim 35-40% of Boeing exposure at $223.06 while maintaining a hard stop at $218 for the retained 60-65% core position; the technical cluster flip (MACD bearish cross, RSI sub-50, close below Bollinger midline at $224.86) and the bull's unsupported valuation math (44.6x at $5 EPS vs. claimed 30-40x) demand an Underweight response rather than full exit or passive hold.
Maintain a moderate position at $225.95 without adding or trimming exposure. The structural thesis (737-7 certification, $62.6B deferred revenue, defense backlog, duopoly moat) and equity inflection from -$8.25B to +$5.99B support retention, but the 54.8x forward P/E, broken near-term momentum (RSI neutral at 50.51, MACD histogram +0.14), and hostile macro conditions (30-year yield at 19-year high) argue against adding at current levels.
Trim 40-50% of Boeing longs at $230-234 over 5-7 trading days while preserving a 50-60% core position, as Q2 2026 revenue declined 7.2% sequentially and EPS deteriorated 6x quarter-over-quarter (-$0.11 to -$0.67), with the $7B/quarter debt paydown funded by balance sheet liquidation rather than operational repair. A hard stop is set at $213 close, with re-entry triggers at $215-218 (50-SMA retest), $200-205 (Bollinger lower band), or breakout above $246 on volume exceeding 8M shares; Q3 2026 earnings (~late October 2026) serves as the decisive catalyst.
Three analysts converge on reducing Boeing exposure, citing stretched 56x forward P/E valuation against four unfavorable binary catalysts (737 ramp quality, 777X timing, defense stabilization, margin expansion) with 777X delivery promises at 0-for-4 historically. The neutral analyst's framework recommends trimming to 50-60% of benchmark weight via tranche execution over 7-10 trading days, front-loading into $235-$240 strength while retaining a small structural core for asymmetric catalyst participation. Re-entry requires close above $245.50 on volume ≥8M shares; add short/put protection if $219 fails on volume >5M targeting $200-$205.
Analyst maintains Hold rating on RTX at $230, retaining the 50-60% core position trimmed on 8/11 rather than adding at current levels. The three re-engagement triggers specified on 8/11 have not been met—the $220-222 pullback support test and $242 breakout conditions remain pending—leaving $230 squarely in the contested $228-234 zone where adding is explicitly discouraged. Upgrade to Overweight is conditioned on any of: pullback to $215-220 with 2-3 weeks of constructive basing, confirmed breakout above $240.19 on volume ≥1.5× 20-day average, or Q2 2026 earnings showing positive operating margin AND positive FCF, with hard stop at $213.50 (200 SMA break + golden cross invalidation).
Trim 40-50% of BA exposure at the $232-$234 zone to lock in gains from the MAX 7 certification rally, while maintaining 50-60% as a core structural position given $5.63B TTM FCF, equity restoration to +$5.98B, and a growing defense backlog. A hard stop at $218 close (2x ATR) protects against thesis invalidation, with re-engagement triggers at confirmed 50 SMA retest ($220-$222 with volume) or two consecutive closes above $242 on ≥7M shares.
Maintaining Hold at benchmark weight with long $215 puts only (no collar) as catastrophic insurance through Q3 2026 earnings, avoiding the theta drag of a full collar that would cap upside at the $245 breakout level. Tiered stop discipline: reduce 50% on close below $220, exit remainder on close below $218 on declining volume. Do not add at current $232 levels; bull add trigger is close above $242 on >5M volume, then add on pullback to $238-240, stop $228, target $251/$260. Q3 2026 earnings is the decisive catalyst on operating income expansion, FCF trajectory, and inventory days.
Maintain BA at current $234 allocation with HOLD rating; do not add into $240-$254 resistance on stretched 56.7x forward multiple and declining volume (3.86M on 8/7 vs 10.99M on 8/3). Risk/reward is approximately symmetric (+12%/-13%) at current levels, making disciplined entry triggers essential to avoid being stopped out given the 7.51 ATR. Implement put hedge (Sept/Dec $220-$225 strikes at 1-2% of position cost) to neutralize binary Q2 earnings and FAA AD overhang while preserving upside if Max 7 monetization delivers.
Get the daily brief — how yesterday's calls actually scored, in your inbox before the open — free with a TraderPunk account.
Create a free accountAlready have one? Sign in to subscribe.